Cd36 Knockout cell line (RAW264.7)
Catalog Number: KO01061
Price: Online Inquiry
Catalog Number: KO01061
Price: Online Inquiry
Product Information | |
---|---|
Product Name | Cd36 Knockout cell line (RAW264.7) |
specification | 1*10^6 |
Storage and transportation | Dry ice preservation/T25 live cell transportation. |
species | Mouse |
Gene | Cd36 |
Gene ID | 12491 |
Build method | Electric rotation method / virus method |
Mycoplasma testing | Negative |
Parental Cell Line | RAW264.7 |
Quality Control | Genotype: Cd36 Knockout cell line (RAW264.7) >95% viability before freezing. All cells were tested and found to be free of bacterial, viruses,mycoplasma and other toxins. |
Gene Information | |
---|---|
Gene Official Full Name | CD36 moleculeprovided by MGI |
Also known as | FAT; GPIV; Scarb3 |
Gene Description | Enables lipoprotein particle binding activity; lipoteichoic acid immune receptor activity; and low-density lipoprotein particle receptor activity. Involved in several processes, including negative regulation of macromolecule biosynthetic process; positive regulation of intracellular signal transduction; and positive regulation of metabolic process. Acts upstream of or within several processes, including phagocytosis; positive regulation of cytokine production; and response to bacterium. Located in several cellular components, including brush border membrane; external side of plasma membrane; and membrane raft. Is expressed in several structures, including axial skeleton; bone; connective tissue; hindlimb; and telencephalon. Used to study platelet-type bleeding disorder 10. Human ortholog(s) of this gene implicated in several diseases, including blood platelet disease (multiple); hemolytic-uremic syndrome; osteoarthritis; pulmonary tuberculosis; and type 2 diabetes mellitus. Orthologous to human CD36 (CD36 molecule (CD36 blood group)). [provided by Alliance of Genome Resources, Apr 2025] |
Expression | Biased expression in subcutaneous fat pad adult (RPKM 144.0), heart adult (RPKM 110.7) and 5 other tissues See more |
We develop gene knockout solutions tailored to customer requirements and the condition of the target gene.
Cas9 Protein
Cas9 mRNA sgRNA
Cas9 Plasmid
Cas9 Virus
A – Exon KO
gRNAs are designed in the introns flanking the exon, targeting non-multiple-of-3 base deletions in the exon, resulting in frameshift mutations.
B - Frameshift KO
gRNAs are designed within the exon, creating non-multiple-of-3 base deletions to induce frameshift mutations.
C - Complete KO
The entire gene coding sequence is deleted, achieving large-scale knockout effects.
KO Strategy Design
CRISPR Plasmid/Lentiviral Vector Construction
Lentiviral Packaging
Cell Transfection/Lentiviral Infection
Drug Selection
Cell Cryopreservation
Quality Control
Sequencing Validation
Monoclonal Cell Line Generation
Pool Efficiency Validation
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.